{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:07:41Z","timestamp":1792681661967,"version":"4.5.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic kidney disease (CKD) in patients with type 2 diabetes mellitus (T2DM) is the major cause of end stage renal disease, characterized by proteinuria with a subsequent decline in glomerular filtration rate. Although hyperglycemia is the major risk factor for the development and progression of kidney disease among diabetic patients, many other risk factors also contribute to structural and functional changes in the kidneys. As recommended by Kidney Disease Improving Global Outcomes (KDIGO), CKD classification based on cause and severity, links to risk of adverse outcomes including mortality and kidney outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The aim of this study is to investigate the involvement of risk factors associated with the severity of CKD among participants with longer duration of diabetes. This study also aims to find whether number of risk factors vary among risk of CKD progression categories based on KDIGO classification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and methods<\/jats:title>\n                    <jats:p>This cross-sectional study retrospectively selected 424 participants from type 2 diabetic cohort and categorized them based on the classifications for the diagnosis of kidney diseases in patients with diabetes, according to the KDIGO guidelines. Odds ratios and 95% CI of each risk factors according to severity of renal disease were determined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Based on KDIGO classification, participants with type 2 diabetes (T2D) were categorized in to low risk (n=174); moderately increased risk (n=98); and high\/very high risk (n=152). Type 2 diabetic participants with risk factors such as, hyperlipidemia, hypertension, DM duration \u226515 years and diabetic retinopathy showed a high\/very high risk of CKD progression when compared with low-risk category. While T2D participants with risk factors such as, lack of exercise, hypertension, and diabetic retinopathy showed a moderately increased risk of CKD progression. In addition, participants with highest number of risk factors were significantly distributed among high\/very high risk of CKD progression category.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study findings conclude that patients with T2DM and duration of \u226515 years, hyperlipidemia, hypertension and diabetic retinopathy have an increased prevalence of advanced CKD. In addition to this, increased number of risk factors could be an indicator of the severity of CKD in T2D.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2022.1079725","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:14:54Z","timestamp":1670544894000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":48,"title":["Risk factors of chronic kidney disease among type 2 diabetic patients with longer duration of diabetes"],"prefix":"10.3389","volume":"13","author":[{"given":"Khalid","family":"Siddiqui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teena P.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salini S.","family":"Joy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assim A.","family":"Alfadda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,9]]},"reference":[{"key":"B1","unstructured":"Brussels, BelgiumIDF diabetes atlas2021"},{"key":"B2","first-page":"49","article-title":"Diabetic kidney disease: world wide difference of prevalence and risk factors","volume":"5","author":"Gheith","year":"2015","journal-title":"J Nephropharmacol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"15018","DOI":"10.1038\/nrdp.2015.18","article-title":"Diabetic kidney disease","volume":"1","author":"Thomas","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"B4","first-page":"1","article-title":"Kidney disease: Improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Levin","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.11070","article-title":"Diabetic kidney disease in type 2 diabetes: A review of pathogenic mechanisms, patient-related factors and therapeutic options","volume":"9","author":"Woodhams","year":"2021","journal-title":"PeerJ"},{"key":"B6","doi-asserted-by":"publisher","first-page":"dci220027","DOI":"10.2337\/dci22-0027","article-title":"Diabetes management in chronic kidney disease: A consensus report by the American diabetes association (ADA) and kidney disease: Improving global outcomes (KDIGO)","volume":"3","author":"de Boer","year":"2022","journal-title":"Diabetes Care"},{"key":"B7","doi-asserted-by":"publisher","first-page":"21501327211048556","DOI":"10.1177\/21501327211048556","article-title":"Risk factors and comorbidities associated with diabetic kidney disease","volume":"12","author":"Roy","year":"2021","journal-title":"J Prim Care Community Health"},{"key":"B8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5144\/0256-4947.2018.03.01.1010","article-title":"The Saudi diabetic kidney disease study (Saudi-DKD): Clinical characteristics and biochemical parameters","volume":"38","author":"Al-Rubeaan","year":"2018","journal-title":"Ann Saudi Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/kisup.2012.64","article-title":"Chapter 1: Definition and classification of CKD","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.7326\/M17-2640","article-title":"Diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder: Synopsis of the kidney disease: Improving global outcomes 2017 clinical practice guideline update","volume":"168","author":"Ketteler","year":"2018","journal-title":"Ann Intern Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2014.03.009","article-title":"Epidemiology and risk factors for diabetic kidney disease","volume":"21","author":"Harjutsalo","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088956","article-title":"Diabetic nephropathy and its risk factors in a society with a type 2 diabetes epidemic: A Saudi national diabetes registry-based study","volume":"9","author":"Al-Rubeaan","year":"2014","journal-title":"PloS One"},{"key":"B13","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.2337\/dc15-S005","article-title":"Classification and diagnosis of diabetes","volume":"38","year":"2015","journal-title":"Diabetes Care"},{"key":"B14","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0161-6420(13)38012-9","article-title":"Grading diabetic retinopathy from stereoscopic colour fundus photographs-an extension of the modified airlie house classification. ETDRS report number 10","volume":"98","year":"1991","journal-title":"Ophthalmology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2019.05.003","article-title":"Blood pressure and the new ACC\/AHA hypertension guidelines","volume":"30","author":"Flack","year":"2020","journal-title":"Treands Cardiovasc Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2337\/db09-9028","article-title":"From the triumvirate to the ominous octet: A new paradigm for the treatment of type 2 diabetes mellitus","volume":"58","author":"De Fronzo","year":"2009","journal-title":"Diabetes"},{"key":"B18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13098-016-0159-z","article-title":"Interactions between kidney disease and diabetes: Dangerous liaisons","volume":"8","author":"Pecoits-Filho","year":"2016","journal-title":"Diabetol Metab Syndr"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: Challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0000000000000745","article-title":"Lifestyle interventions for preventing and ameliorating CKD in primary and secondary care","volume":"30","author":"Kelly","year":"2021","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61272-0","article-title":"Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: A meta-analysis","volume":"380","author":"Mahmoodi","year":"2012","journal-title":"Lancet"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000158434.69180.2D","article-title":"Low-grade albuminuria and the risks of hypertension and blood pressure progression","volume":"111","author":"Wang","year":"2005","journal-title":"Circulation."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.5935\/abc.20190077","article-title":"Kidney disease in diabetes mellitus: Cross-linking between hyperglycemia, redox imbalance and inflammation","volume":"112","author":"Amorim","year":"2019","journal-title":"Arq Bras Cardiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"6757916","DOI":"10.1155\/2021\/6757916","article-title":"Incidence of diabetic nephropathy and its predictors among type 2 diabetes mellitus patients at university of gondar comprehensive specialized hospital, Northwest Ethiopia","volume":"2021","author":"Kebede","year":"","journal-title":"J Nutr Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.314.7083.783","article-title":"Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: Prospective, observational study","volume":"314","author":"Gall","year":"1997","journal-title":"BMJ."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(04)01079-0","article-title":"Albuminuria is evident in the early stages of diabetes onset: Results from the Australian diabetes, obesity, and lifestyle study (AusDiab)","volume":"44","author":"Tapp","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1136\/bmj.38070.450891.FE","article-title":"Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: Inception cohort study","volume":"328","author":"Hovind","year":"2004","journal-title":"BMJ"},{"key":"B28","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1186\/s13104-018-3670-5","article-title":"Diabetic nephropathy and hypertension in diabetes patients of sub-Saharan countries: A systematic review and meta-analysis","volume":"11","author":"Wagnew","year":"2018","journal-title":"BMC Res Notes"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00712.x","article-title":"Development and progression of nephropathy in type 2 diabetes: The united kingdom prospective diabetes study (UKPDS 64)","volume":"63","author":"Adler","year":"2003","journal-title":"Kidney Int"},{"key":"B30","article-title":"The prevalence and risk factors of diabetic nephropathy in Taiwanese type 2 diabetes - a hospital based study","volume":"23","author":"Shen","year":"2009","journal-title":"ActaNephrologica"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-021-02429-4","article-title":"Diabetic kidney disease in patients with type 2 diabetes mellitus: A cross-sectional study","volume":"22","author":"Farah","year":"2021","journal-title":"BMC Nephrol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02920608","article-title":"Physical activity and hemodynamic reactivity in chronic kidney disease","volume":"3","author":"Agarwal","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12882-016-0400-x","article-title":"Physical activity and metabolic health in chronic kidney disease: A cross-sectional study","volume":"17","author":"Bowlby","year":"2016","journal-title":"BMC Nephrol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1159\/000156715","article-title":"Effect of exercise on cardiac tissue oxidative and inflammatory mediators in chronic kidney disease","volume":"29","author":"Bai","year":"2009","journal-title":"Am J Nephrol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.861005","article-title":"Physical exercise prevents cellular senescence in circulating leukocytes and in the vessel wall","volume":"120","author":"Werner","year":"2009","journal-title":"Circulation."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12789","article-title":"Enhanced fitness and renal function in type 2 diabetes","volume":"32","author":"Nylen","year":"2015","journal-title":"Diabetes Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2013.10.048","article-title":"Markers and risk factors for the development and progression of diabetic kidney disease","volume":"63","author":"Macisaac","year":"2014","journal-title":"Am J Kidney Dis"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1079725\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:14:59Z","timestamp":1670544899000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1079725\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,9]]},"references-count":37,"alternative-id":["10.3389\/fendo.2022.1079725"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.1079725","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,9]]},"article-number":"1079725"}}